HomeALZN • NASDAQ
add
Alzamend Neuro Inc
Previous close
$2.35
Day range
$2.28 - $2.41
Year range
$2.06 - $15.30
Market cap
8.90M USD
Avg Volume
144.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.70M | 180.57% |
Net income | -2.70M | -177.37% |
Net profit margin | — | — |
Earnings per share | -1.28 | 88.62% |
EBITDA | -2.67M | -181.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.62M | 370.78% |
Total assets | 6.33M | 278.88% |
Total liabilities | 983.31K | -65.88% |
Total equity | 5.34M | — |
Shares outstanding | 3.14M | — |
Price to book | 1.38 | — |
Return on assets | -123.53% | — |
Return on capital | -144.99% | — |
Cash Flow
Net change in cash
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -2.70M | -177.37% |
Cash from operations | -2.36M | -123.80% |
Cash from investing | — | — |
Cash from financing | 4.04M | 105.49% |
Net change in cash | 1.67M | 104.45% |
Free cash flow | -1.35M | -70.58% |
About
Founded
2016
Headquarters
Website
Employees
6
